Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
Author:
Funder
United Therapeutics Corporation
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues;Y Ohmi;Neurochemical research,2012
2. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients;G Schulz;Cancer research,1984
3. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells;NK Cheung;Cancer research,1985
4. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;AL Yu;The New England journal of medicine,2010
5. Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial;R Mody;The Lancet Oncology,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine;Pharmaceutics;2023-02-15
2. Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma;Current Pharmacology Reports;2022-12-31
3. A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics;Molecular Therapy - Nucleic Acids;2021-12
4. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy;International Journal of Nanomedicine;2021-05
5. Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032;Clinical Cancer Research;2021-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3